97 results
Page 3 of 5
8-K
EX-99.1
pxvu8mleaak
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.1
2ofg7w64eiwlq
22 Nov 19
Other Events
5:01pm
424B5
gy5rv1dubkc
8 Nov 19
Prospectus supplement for primary offering
5:03pm
8-K
EX-1.1
36atw1y446ut4rw8qz
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
424B5
5jhe1jnp94kg pxikgee
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
recpx1vik6ugx80a1
4 Sep 19
Other Events
5:05pm
8-K
EX-99.1
epiqw3u75pdzq39
3 Jun 19
Other Events
4:02pm
8-K
EX-99.1
yrqmt2hxmrulx 0ra
2 May 19
Other Events
3:24pm
8-K
EX-3.1
fidxiy fywwid1odgpqo
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.2
7ojql 9ckn
3 Dec 18
Other Events
4:03pm
8-K
EX-99.1
5ne6x
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.1
ivxja umhf
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
unnw924iw1
4 May 18
Results of Operations and Financial Condition
7:07am